GLP-1 Drugs Like Ozempic Linked to Rare Blinding Disease

In an observational retrospective study, researchers found that patients with type 2 diabetes or obesity who were taking semaglutide were more likely to develop a rare blinding condition than those taking a non-GLP-1 drug.

July 8, 2024   TODAY'S TOP STORY GLP-1 Drugs Like Ozempic Linked to Rare Blinding Disease READ ON   SPECIAL FEATURE 7 Intermittent Fasting Myths Debunked by Dietitians READ ON   Gastroparesis Diet READ ON   The Progression of COPD: What It Looks Like READ ON MORE STORIES RESOURCE FOR YOU With Bezzy for Depression, you're never alone.   If you're living with depression, join others who understand what you're going through. Discover a safe space to find community, guidance, and support together. LEARN MORE Bezzy and Healthline are owned by RVO Health.   HEALTHLINE VIDEO     Through An Artist's Eye Video tips and stories about breast cancer and honest conversations with people in the breast cancer community. WATCH NOW         HEALTHLINE RESOURCE Hunger Cues With Abbey Sharp   Do you ever find that no matter how much you eat, you're never full? Learn more about this from Abbey Sharp, a registered dietician. LEARN MORE What we're reading next • Psoriasis on Black Skin vs. White Skin • Does Medicare Cover Breast Reduction Surgery? • 11 Potential Physical and Mental Health Benefits of Pets • What Are the Risk Factors for Psoriasis? Until then, Take care of yourself, and we'll see you again soon! View in browser Did a friend send you this email? Subscribe here. To see all newsletters, click here. Privacy   |   Unsubscribe Our website services, content, and products are for informational purposes only. Healthline does not provide medical advice, diagnosis, or treatment and should not be used as a substitute for medical advice from a healthcare professional. Healthline encourages you to make any treatment decisions with your healthcare professional. Healthline is owned by RVO Health. © 2024 RVO Health 1101 Red Ventures Drive Fort Mill, SC 29707